Invion (AU:IVX) has released an update.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Invion Limited has issued over half a million new shares and is in talks with RMW Cho Group Limited to potentially expand its Photosoft™ technology rights. Known for advancing photodynamic therapy for cancer treatment, Invion is leveraging its ASX listing to drive innovation in the medical field. These developments could impact the company’s market position and attract investor interest.
For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.